May 08, 2024 / 08:30PM GMT
Operator
Good afternoon and welcome to the Supernus Pharmaceuticals First Quarter 2024 financial results conference call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. Instructions will follow at that. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of ICR Westwicke, Investor Relations Representative super and U.S. pharmaceuticals. You may now begin.
Peter Vozzo - ICR Westwicke - Investor Relations
Thank you, Mark, and good afternoon, everyone, and thank you for joining us today versus host Pharmaceuticals First Quarter 2024 financial results conference call. Today after the close of the market, the company issued a press release announcing these results on the call with me today are six furnaces Chief Executive Officer, Jack Khattar, and Chief Financial Officer, Tim Dec.
Today's call is being made available via the Investor Relations section of the company's website at ir dot supernus.com. During the course of this call,
Q1 2024 Supernus Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot